A 58-year-old man with a 3-day history of acute onset dyspnea, pleuritic chest pain, and tachycardia (HR 108/min) is admitted to your ward. He had undergone total knee replacement 10 days ago. On examination, he is hypoxic (SpO₂ 88% on room air) with a normal chest X-ray. D-dimer is elevated at 2.8 µg/mL. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient presents with a classic post-operative pulmonary embolism scenario: - **Risk factors:** Recent major orthopedic surgery (total knee replacement — highest VTE risk category), immobility, age >50 - **Clinical signs:** Acute dyspnea, pleuritic chest pain, tachycardia (HR 108/min), significant hypoxia (SpO₂ 88%) - **Supportive investigations:** Markedly elevated D-dimer (2.8 µg/mL), normal CXR (excludes pneumonia, pneumothorax, effusion) ## Why Empirical Anticoagulation While Awaiting CTPA is Correct **Key Point:** Per ESC 2019 and ACCP 2021 guidelines, in a hemodynamically stable patient with **high clinical probability** of PE (Wells score ≥5 or Geneva score high), anticoagulation should be initiated **immediately** while awaiting confirmatory imaging — provided there are no absolute contraindications. This patient has: 1. **High pre-test probability** — recent major orthopedic surgery + classic triad of dyspnea, pleuritic pain, tachycardia + hypoxia + elevated D-dimer 2. **No hemodynamic instability** — CTPA is still the appropriate confirmatory test, but it should not delay anticoagulation 3. **Significant hypoxia (SpO₂ 88%)** — underscores urgency; delay in anticoagulation risks clot propagation and hemodynamic deterioration **High-Yield:** ESC 2019 PE Guidelines (Konstantinides et al.) explicitly state: *"In patients with high clinical probability, anticoagulation should be initiated while awaiting the results of diagnostic tests."* UFH is preferred in the peri-operative setting because it is rapidly reversible and titratable. ## Why Other Options Are Incorrect | Option | Reason Incorrect | |--------|-----------------| | A — Empirical antibiotics | No evidence of infection; normal CXR; clinical picture is PE, not pneumonia | | B — CTPA alone (defer anticoagulation) | Guideline-discordant in high-probability PE; risks clot propagation during imaging delay | | D — V/Q scan + defer anticoagulation | V/Q scan is second-line (used when CTPA contraindicated); deferring anticoagulation in high-probability PE is dangerous | ## Management Pathway ``` High clinical suspicion for PE (stable patient) ↓ Start UFH bolus + infusion IMMEDIATELY ↓ Arrange urgent CTPA ↓ PE confirmed? → Continue anticoagulation (transition to LMWH/DOAC) PE excluded? → Stop anticoagulation, investigate alternative diagnosis ``` **Clinical Pearl:** The key distinction is between *intermediate-high probability* and *low probability* PE. In low-probability cases, imaging precedes anticoagulation. In **high-probability** cases (as here), anticoagulation precedes or runs concurrent with imaging. UFH is preferred over LMWH in the immediate post-operative period due to its reversibility with protamine sulfate. *(Harrison's Principles of Internal Medicine, 21e, Ch. 273; ESC Guidelines on PE, 2019)*